Actinium Pharmaceuticals
ATNM
#8874
Rank
NZ$90.64 M
Marketcap
$2.91
Share price
-4.26%
Change (1 day)
-72.43%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2024 (TTM): -NZ$76.77 M

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -NZ$75.5 M. In 2023 the company made an earning of -NZ$83.93 M a decrease over its 2022 earnings that were of -NZ$55.13 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$76.77 M-8.53%
2023 -NZ$83.93 M52.24%
2022 -NZ$55.13 M36.61%
2021 -NZ$40.36 M11.48%
2020 -NZ$36.2 M1.46%
2019 -NZ$35.68 M-7.37%
2018 -NZ$38.52 M-11.46%
2017 -NZ$43.5 M10.67%
2016 -NZ$39.31 M15.7%
2015 -NZ$33.98 M-14.86%
2014 -NZ$39.91 M129.19%
2013 -NZ$17.42 M-8.55%
2012 -NZ$19.04 M
2010 NZ$0.01 M-152.15%
2009 -NZ$0.03 M-39.8%
2008 -NZ$0.05 M120.29%
2007 -NZ$0.02 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$60.12 M-20.38%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.48 B-739.45%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.17 B 113.75%๐Ÿ‡บ๐Ÿ‡ธ USA